Li, Z., Li, F., Yi, S., Gu, Z., Yu, Z., Xu, Y., . . . Qiu, L. (2015). Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: Long-term results from a single center in China. BMC Cancer.
Čikaški stil citiranjaLi, Zengjun, et al. "Superior Efficacy of Rituximab-based Chemoimmunotherapy As an Initial Therapy in Newly Diagnosed Patients With B Cell Indolent Lymphomas: Long-term Results From a Single Center in China." BMC Cancer 2015.
MLA način citiranjaLi, Zengjun, et al. "Superior Efficacy of Rituximab-based Chemoimmunotherapy As an Initial Therapy in Newly Diagnosed Patients With B Cell Indolent Lymphomas: Long-term Results From a Single Center in China." BMC Cancer 2015.